FILTER

FILTERED INTERVIEW RESULTS

Bassil Dahiyat

PRESIDENT AND CEO, XENCOR
Powered by its XmAb antibody engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat autoimmune disorders, cancer, asthma and allergic diseases.

Mark Ridley-Thomas

SUPERVISOR, LOS ANGELES COUNTY BOARD OF SUPERVISORS
The Board of Supervisors is the governing body of the County of Los Angeles, a charter county with a population of 10 million people and a budget of $33 billion. The Board has the unique function of serving as the executive and legislative head of the largest and most complex county government in the entire United States.

Justin Schroeder

SENIOR EXECUTIVE DIRECTOR – GLOBAL MARKETING & DESIGN, PCI PHARMA SERVICES
PCI Pharma Services provides integrated pharmaceutical development services to the global healthcare market.

Gustavo Mahler

CEO, AGC BIOLOGICS
AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, using mammalian and microbial production systems.

Chris Rector

VICE PRESIDENT – SOURCING AND SUPPLIER RELATIONS, CLARUSONE SOURCING SERVICES
Based in London, UK, ClarusONE Sourcing Services provides strategic services that allow McKesson Corporation and Walmart, Inc., to jointly source generic pharmaceuticals.

David H. Crean

MANAGING DIRECTOR, INVESTMENT BANKING, OBJECTIVE CAPITAL PARTNERS
Objective Capital Partners, headquartered in Southern California, is a leading mergers and acquisitions (M&A) investment banking firm focused on transactions for privately held companies with enterprise values up to US$500 million.

Vidya Vasu-Devan

DEPUTY DIRECTOR, BILL & MELINDA GATES FOUNDATION’S STRATEGIC INVESTMENT FUND
The Bill & Melinda Gates Foundation is the largest private foundation in the United States. Its Strategic Investment Fund (SIF) works to leverage the might of the private sector to achieve progress on the foundation’s charitable objectives.

Raul Rodriguez

PRESIDENT AND CEO, RIGEL
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and commercializing novel small molecule drugs for immune and hematologic disorders, cancer and rare diseases.

Elizabeth Jeffords

CHIEF COMMERCIAL & STRATEGY OFFICER, ALKAHEST
Alkahest has a unique technology platform for elucidating changes in the plasma proteome in healthy aging and in age-related diseases.

Michael Quirmbach

CHIEF BUSINESS OFFICER, CORDENPHARMA
CordenPharma is a CDMO supporting pharma and biotech companies, with cGMP facilities across Europe & the US.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2022 - Digital Version

PARTNER EVENTS